Previous Page  2 / 6 Next Page
Information
Show Menu
Previous Page 2 / 6 Next Page
Page Background

Page 20

May 20-21, 2019 | Rome, Italy

Journal of Cell Science and Mutation | Volume 3

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Stem Cell Congress 2019

STEM CELLS AND REGENERATIVE MEDICINE

2

nd

International Conference on

AMNIOFIX IN REFRACTORY KNEE PAIN

Ashish Anand

University of Mississippi Medical center, USA

T

he amniotic membrane is a constituent of placental tissue that protects and supports the fetus in utero. It

is composed of extracellular matrix components such as collagen, fibronectin and laminin, contains many

different growth factors and cytokines. The healing properties of amniotic tissue were first identified in 1910

where it was discovered that they help in healing refractory stalled wounds. However this immunologically

privileged structure was lost to scientific community for close to 90 years until technological advances led to

its being “rediscovered” in 2000. Author reporting his retrospective case series of 40 patients of variable age

group who had failed all conservative treatment options including all other injections like steroids and vis-

cosupplementation and were reluctant for surgery. Patients were injected with AmnioFix injection and were

followed at four weeks and eight weeks and six months and contacted at one year. Failure rate was defined as

improvement of <50% in VAS scale. 65% patients reported improvement in there VAS pain levels of more than

60% and 25% reported improvements of 50% and 10% did not have any improvement. The majority group

above reported improvement in their walking distance. Based on above failure rate was 10-25% which was

defined as need of other treatments/surgery. This retrospective review of cases suggests that AmnioFix can be

used in treatment of refractory arthritic knee pain. To the best of our knowledge this is a second follow up series

in English Literature elucidating the benefits of AmnioFix in osteoarthritis. As technology advances and price

become affordable the research world will hear more about this product.

Adv Cell Sci Mut. 2019, Volume 3